Oh Leronlimab the great sleeper is beginning to awake.It is a simple fact that won't be denied as it is based in truth, the real science, not the political science that will fall by the wayside before all said and done.
Come back Nadaaaa. I need those cheapies. LMAO. The second coming...for about the 100th time. Wow what a washing machine stuck on rinse cycle. Won't be long and all will be MIRACLE MAB CLEAN.
DR. FALSI admits there has been no testing on the vax for children.
Secondary side effects bringing death at a clip never before seen. Sudden Death Syndrome taking out athletes at an alarming pace not seen before. It's getting worse by the week as the spike protein continues to grow and multiply. That is the real TIK TOK.
My neighbor died on Tuesday. She so believed in Pfizer, however she won't be rising on the third day unfortunately. Which Pfizer jab did she get? The one approved recently or the one under EUA?????
QUESTION? THIS IS THE FDA WE ARE WAITING ON FOR CytoDyns' Leronlimab APPROVALS???
Ghost Shot: Pfizer quietly admits it will never manufacture original FDA approved COVID vaccines
Company claims it is manufacturing Comirnaty product with new formula.
Jordan Schachtel
Jun 3
The August 23, 2021 FDA approval of Pfizer’s Comirnaty vaccine was a cause for celebration.
cnn.it/3D3Q7ci
Twitter avatar for @BridgetNasoBridget Naso @BridgetNaso
Dr. Anthony Fauci said surveys show 30% of unvaccinated Americans said if the vaccine was FDA approved they would get the shot. It was approved today and Fauci said “The time has come.”
It was celebrated as a cause for national relief, and many Americans arrived at their local pharmacies under the impression, via government and pharmaceutical news, that they were receiving an FDA-approved COVID vaccine. Yet that legally distinct product, as we know it, never existed. And now we know, via Pfizer, that it will never exist.
For the uninitiated:
Comirnaty is a legally distinct product from the emergency use authorization (EUA) shots, and It has never made its way to market. For months on end, no such vaccine has ever become available. Those who received the “Pfizer shot(s)” have been injected with the emergency use authorization (EUA) version of the shots.
Shell Game? There remains no FDA approved COVID vaccine in the United States
I fact checked the fact checkers and couldn’t believe what I found. Despite the corporate press, Big Pharma, and the federal government telling us otherwise, it is absolutely true that there is no FDA approved COVID-19 vaccine available in the United States today. And there are no plans to make one available any time soon…
The information operation succeeded. There was indeed an FDA approved vaccine, at least on paper, but you couldn’t get it.
When originally confronted with this ordeal, Pfizer labeled this issue an inventory question that had nothing to do with the legal distinction between an experimental EUA product and an FDA-approved vaccine. Up until just weeks ago, this was the statement up on the CDC website via Pfizer:
“Pfizer received FDA BLA license on 8/23/2021 for its COVID-19 vaccine for use in individuals 16 and older (COMIRNATY). At that time, the FDA published a BLA package insert that included the approved new COVID-19 vaccine tradename COMIRNATY and listed 2 new NDCs (0069-1000-03, 0069-1000-02) and images of labels with the new tradename.
At present, Pfizer does not plan to produce any product with these new NDCs and labels over the next few months while EUA authorized product is still available and being made available for U.S. distribution. As such, the CDC, AMA, and drug compendia may not publish these new codes until Pfizer has determined when the product will be produced with the BLA labels.”
In May, Pfizer updated its statement to mention a December 2021 licensed Comirnaty product, which was granted a license four months after the highly-publicized August FDA press release.
And just last week, Pfizer finally acknowledged that its original licensed product will never be distributed. In an unreported update on the CDC website, Pfizer told the agency:
“Pfizer received initial FDA BLA license on 8/23/2021 for its COVID-19 vaccine for use in individuals 16 and older (COMIRNATY). At that time, the FDA published a BLA package insert that included the approved new COVID-19 vaccine tradename COMIRNATY and listed 2 new NDCs (0069-1000-03, 0069-1000-02) and images of labels with the new tradename. These NDCs will not be manufactured. Only NDCs for the subsequently BLA approved tris-sucrose formulation will be produced.”
The key distinction between the originally approved formulation and the tris-sucrose formulation is that — according to manufacturers — the latter can be held for a much longer period of time outside of an ultra cold freezer. These freezers cost over $10,000 a piece and each unit uses as much energy per day as an average American household. Improper storage can render the mRNA unstable.
Notably, the clinical trials for the Pfizer shot were conducted without the modified tris-sucrose ingredient. Given the partisan nature of Pfizer, the corporate media, government health bureaucracies, and your correspondent’s lack of expertise in this area, it is unclear whether this is significant.
Another notable thing to look out for in the coming days and weeks is the possibility that the subsequently FDA approved product finally becomes available in the United States. In recent days, the CDC removed the language of “not orderable at this time” above the description of both Comirnaty and Moderna’s Spikevax.
Additionally, as reported by Uncover DC, the Defense Department appears to be in the early stages of ordering what it has interpreted as a legally required minimum of Comirnaty in order to continue its mRNA mandate of American service members.
MY FELLOW INVESTOR FRIENDS, WE CYTODYN SHAREHOLDERS ARE BEING PLAYED BIG TIME AS THIS SAME FDA HAS USED EVERY DIRT BAG TRICK IN THE BOOK TO KEEP LERONLIMAB OFF THE MARKET FOR MULTIPLE INDICATIONS GOING WAY BACK TO THE 90'S FOR HIV. FAUCI HAS INTIMATE KNOWLEDGE OF THE EFFECTIVENESS OF LERONLIMAB FOR DECADES.
WILL WE GET A NEW CEO THAT CAN MAKE A DIFFERENCE? A PROVEN SAMSUNG BIOLOGICS SCIENTIST EXECUTIVE WOULD BE MY CHOICE. THEY HAVE MORE MONEY THAN GOD AND COULD VERTICALLY TAKE THE DRUG FROM THEIR MANUFACTURING LAB TO THE KITCHEN CABINET ALL OUTSIDE THE USA...then watch the screaming begin for it's importation. Screw the FDA. Go international! That is the quickest route IMO.
